A final common pathway for depression? Progress toward a general conceptual framework

Neuroscience and Biobehavioral Reviews

Volumn 32, Issue 3, 2008, Pages 508-524

  Stone, Eric A ^a   Lin, Yan ^a   Quartermain, David ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Corticosteroids; Cytokines; Depression; Final common pathway; fos; Monoamines; Neuroimaging; Neurotrophins; Theory

Indexed keywords

ALPHA 1A ADRENERGIC RECEPTOR; ALPHA 1B ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIDEPRESSANT AGENT; CLONIDINE; CORTICOSTEROID; CORTICOSTERONE; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CYTOKINE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR STIMULATING AGENT; GLUCOCORTICOID RECEPTOR; HISTAMINE H1 RECEPTOR; MINERALOCORTICOID RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MONOAMINE; NEUROTROPHIN; NORADRENALIN; QUINPIROLE; SEROTONIN 1 RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN 2C RECEPTOR;

ADRENERGIC SYSTEM; BEHAVIOR; BRAIN BLOOD FLOW; BRAIN MAPPING; CENTRAL NERVOUS SYSTEM; CORTICOSTEROID THERAPY; CYTOKINE PRODUCTION; DEPRESSION; DOSE RESPONSE; DRUG MECHANISM; ENZYME PHOSPHORYLATION; HORMONE ACTION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE SYSTEM; MENTAL DISEASE; MOTIVATION; NEUROIMAGING; NEUROIMMUNOLOGY; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; NONHUMAN; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; REVIEW; STRESS;

ADRENAL CORTEX HORMONES; ANIMALS; ANTIDEPRESSIVE AGENTS; BRAIN MAPPING; CYTOKINES; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; HUMANS; MICE; MOTIVATION; NERVE GROWTH FACTORS; NEURAL PATHWAYS; REWARD; STRESS, PSYCHOLOGICAL;

EID: 38649134764     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2007.08.007     Document Type: Review

References (240)

1. Alfonso J., Pollevick G.D., Van Der Hart M.G., Flugge G., Fuchs E., and Frasch A.C. Identification of genes regulated by chronic psychosocial stress and antidepressant treatment in the hippocampus. European Journal of Neuroscience 19 (2004) 659-666
2. Amat J., Baratta M.V., Paul E., Bland S.T., Watkins L.R., and Maier S.F. Medial prefrontal cortex determines how stressor controllability affects behavior and dorsal raphe nucleus. Nature Neuroscience 8 (2005) 365-371
3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, DSM-IV (2002), American Psychiatric Association, Washington, DC
4. Anisman H., Hayley S., Turrin N., and Merali Z. Cytokines as a stressor: implications for depressive illness. International Journal of Neuropsychopharmacology 5 (2002) 357-373
5. Arana G.W., Santos A.B., Laraia M.T., McLeod-Bryant S., Beale M.D., Rames L.J., Roberts J.M., Dias J.K., and Molloy M. Dexamethasone for the treatment of depression: a randomized, placebo-controlled, double-blind trial. American Journal of Psychiatry 152 (1995) 265-267
6. Arborelius L., Owens M.J., Plotsky P.M., and Nemeroff C.B. The role of corticotropin-releasing factor in depression and anxiety disorders. Journal of Endocrinology 160 (1999) 1-12
7. Arlt W., and Allolio B. Adrenal insufficiency. Lancet 361 (2003) 1881-1893
8. Arnsten A.F.T., and Cai J.X. Postsynaptic alpha-2 receptor stimulation improves memory in aged monkeys; indirect effects of yohimbine versus direct effects of clonidine. Neurobiology of Aging 14 (1993) 597-603
9. Arnsten A.F.T., and Li B.M. Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions. Biological Psychiatry 57 (2005) 1377-1384
10. Arnsten A.F.T., Mathew R., Ubriani R., Taylor J.R., and Bao-Ming L. a-1 Noradrenergic receptor stimulation impairs prefrontal cortical cognitive function. Biological Psychiatry 45 (1999) 26-31
11. Asnis G.M., Halbreich U., Rabinovich H., Ryan N.D., Sachar E.J., Nelson B., Puig-Antich J., and Novacenko H. The cortisol response to desipramine in endogenous depressives and normal control subjects: preliminary findings. Psychiatry Research 14 (1985) 225-233
12. Avgustinovich D.F., Kovalenko I.L., and Kudryavtseva N.N. A model of anxious depression: persistence of behavioral pathology. Neuroscience and Behavioral Physiology 35 (2005) 917-924
13. Bale T.L., and Vale W.W. CRF and CRF receptors: role in stress responsivity and other behaviors. Annual Reviews in Pharmacology and Toxicology 44 (2004) 525-557
14. Ballesteros J., and Callado L.F. Effectiveness of pindolol plus serotonin uptake inhibitors in depression: a meta-analysis of early and late outcomes from randomised controlled trials. Journal of Affective Disorders 79 (2004) 137-147
15. Barbas H., Saha S., Rempel-Clower N., and Ghashghaei T. Serial pathways from primate prefrontal cortex to autonomic areas may influence emotional expression. BMC Neuroscience 4 (2003) 25
16. Basheer R., Sherin J.E., Saper C.B., Morgan J.I., McCarley R.W., and Shiromani P.J. Effects of sleep on wake-induced c-fos expression. Journal of Neuroscience 17 (1997) 9746-9750
17. Baxter Jr. L.R., Schwartz J.M., Phelps M.E., Mazziotta J.C., Guze B.H., Selin C.E., Gerner R.H., and Sumida R.M. Reduction of prefrontal cortex glucose metabolism common to three types of depression. Archives of General Psychiatry 46 (1989) 243-250
18. Berns G.S., and Nemeroff C.B. The neurobiology of bipolar disorder. American Journal of Medical Genetics 123C (2003) 76-84
19. Berridge C.W., Isaac S.O., and España R.A. Additive wake-promoting actions of medial basal forebrain noradrenergic a1- and b-receptor stimulation. Behavioral Neuroscience 117 (2003) 350-359
20. Bertini G., Peng Z.C., Fabene P.F., Grassi-Zucconi G., and Bentivoglio M. Fos induction in cortical interneurons during spontaneous wakefulness of rats in a familiar or enriched environment. Brain Research Bulletin 57 (2002) 631-638
21. Berton O., McClung C.A., DiLeone R.J., Krishnan V., Renthal W., Russo S.J., Graham D., Tsankova N.M., Bolanos C.A., Rios M., Monteggia L.M., Self D.W., and Nestler E.J. Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 311 (2006) 864-868
22. Bing G., Filer D., Miller J.C., and Stone E.A. Noradrenergic activation of immediate early genes in rat cerebral cortex. Molecular Brain Research 11 (1991) 43-46
23. Bisagno V., Ferrini M., Rios H., Zieher L., and Wikinski S. Chronic corticosterone impairs inhibitory avoidance in rats: possible link with atrophy of hippocampal CA3 neurons. Pharmacology Biochemistry and Behavior 66 (2000) 235-240
24. 1A agonists in the treatment of depression?. Biological Psychiatry 53 (2003) 193-203
25. Blumberg H.P., Leung H.C., Skudlarski P., Lacadie C.M., Fredericks C.A., Harris B.C., Charney D.S., Gore J.C., Krystal J.H., and Peterson B.S. A functional magnetic resonance imaging study of bipolar disorder: state- and trait-related dysfunction in ventral prefrontal cortices. Archives of General Psychiatry 60 (2003) 601-609
26. Boyson S.J., McGonigle P., and Molinoff P.B. Quantitative autoradiographic localization of the D1 and D2 subtypes of dopamine receptors in rat brain. Journal of Neuroscience 6 (1986) 3177-3188
27. Bremner J.D., Vythilingam M., Ng C.K., Vermetten E., Nazeer A., Oren D.A., Berman R.M., and Charney D.S. Regional brain metabolic correlates of a-methylparatyrosine-induced depressive symptoms-Implications for the neural circuitry of depression. JAMA 289 (2003) 3125-3134
28. Brown A.S., and Gershon S. Dopamine and depression. Journal of Neural Transmission 91 (1993) 75-109
29. Brown E.S., and Suppes T. Mood symptoms during corticosteroid therapy: a review. Harvard Review of Psychiatry 5 (1998) 239-246
30. Bruijnzeel A.W., Stam R., Compaan J.C., and Wiegant V.M. Stress-induced sensitization of CRH-ir but not P-CREB-irresponsivity in the rat central nervous system. Brain Research 908 (2001) 187-196
31. 1-adrenergic receptor expression during endotoxemia. Critical Care Medicine 31 (2003) 566-571
32. Buchman A.L. Side effects of corticosteroid therapy. Journal of Clinical Gastroenterology 33 (2001) 289-294
33. Cabib S., and Puglisi-Allegra S. Stress, depression and the mesolimbic dopamine system. Psychopharmacology 128 (1996) 331-342
34. Camps M., Cortes R., Gueye B., Probst A., and Palacios J.M. Dopamine receptors in human brain: autoradiographic distribution of D2 sites. Neuroscience 28 (1989) 275-290
35. Carroll B.J., Cassidy F., Naftolowitz D., Tatham N.E., Wilson W.H., Iranmanesh A., Liu P.Y., and Veldhuis J.D. Pathophysiology of hypercortisolism in depression. Acta Psychiatrica Scandinavica 115 (2007) 90-103
36. Cecchi M., Khoshbouei H., Javors M., and Morilak D.A. Modulatory effects of norepinephrine in the lateral bed nucleus of the stria terminalis on behavioral and neuroendocrine responses to acute stress. Neuroscience 112 (2002) 13-21
37. Cecchi M., Khoshbouei H., and Morilak D.A. Modulatory effects of norepinephrine, acting on alpha1 receptors in the central nucleus of the amygdala, on behavioral and neuroendocrine responses to acute immobilization stress. Neuropharmacology 43 (2002) 1139-1147
38. Chang K., Adleman N.E., Dienes K., Simeonova D.I., Menon V., and Reiss A. Anomalous prefrontal-subcortical activation in familial pediatric bipolar disorder: a functional magnetic resonance imaging investigation. Archives of General Psychiatry 61 (2004) 781-792
39. Cirelli C., Pompeiano M., and Tononi G. Sleep deprivation and c-fos expression in the rat brain. Journal of Sleep Research 4 (1995) 92-106
40. Coddington E., Lewis C., Rose J.D., and Moore F.L. Endocannabinoids mediate the effects of acute stress and corticosterone on sex behavior. Endocrinology 148 (2007) 493-500
41. Cornil C.A., Balthazart J., Motte P., Massotte L., and Seutin V. Dopamine activates noradrenergic receptors in the preoptic area. Journal of Neuroscience 22 (2002) 9320-9330
42. Craig A.D. Human feelings: why are some more aware than others?. Trends in Cognitive Sciences 8 (2004) 239-241
43. Cryan J.F., Page M.E., and Lucki I. Noradrenergic lesions differentially alter the antidepressant- like effects of reboxetine in a modified forced swim test. European Journal of Pharmacology 436 (2002) 197-205
44. Cyr M., Morissette M., Barden N., Beaulieu S., Rochford J., and Di Paolo T. Dopaminergic activity in transgenic mice underexpressing glucocorticoid receptors: effect of antidepressants. Neuroscience 102 (2001) 151-158
45. D'Aquila P.S., Peana A.T., Carboni V., and Serra G. Different effect of desipramine on locomotor activity in quinpirole-treated rats after repeated restraint and chronic mild stress. European Journal of Pharmacology 399 (2000) 43-47
46. Dantzer R. Cytokine, sickness behavior, and depression. Neurologic Clinics 24 (2006) 441-460
47. Davidson R. Affective style and affective disorders: perspectives from affective neuroscience. Cognition and Emotion 12 (1998) 307-330
48. Davis M., Walker D.L., and Lee Y. Amygdala and bed nucleus of the stria terminalis: differential roles in fear and anxiety measured with the acoustic startle reflex. Philosophical Transactions of the Royal Society of London Series B: Biological Sciences 352 (1997) 1675-1687
49. Dayas C.V., Buller K.M., and Day T.A. Hypothalamic paraventricular nucleus neurons regulate medullary catecholamine cell responses to restraint stress. Journal of Comparative Neurology 478 (2004) 22-34
50. de Kloet E.R., Joels M., and Holsboer F. Stress and the brain: from adaptation to disease. Nature Reviews in Neuroscience 6 (2005) 463-475
51. de Kloet E.R., Sibug R.M., Helmerhorst F.M., and Schmidt M. Stress, genes and the mechanism of programming the brain for later life. Neuroscience and Biobehavioral Reviews 29 (2005) 271-281
52. De La Garza II R. Endotoxin- or pro-inflammatory cytokine-induced sickness behavior as an animal model of depression: focus on anhedonia. Neuroscience and Biobehavioral Reviews 29 (2005) 761-770
53. DeBattista C., Posener J.A., Kalehzan B.M., and Schatzberg A.F. Acute antidepressant effects of intravenous hydrocortisone and CRH in depressed patients: a double-blind, placebo-controlled study. American Journal of Psychiatry 157 (2000) 1334-1337
54. Dechant G., and Neumann H. Neurotrophins. Advances in Experimental Medicine and Biology 513 (2002) 303-334
55. Delfs J., Druhan J., and Aston-Jones G. Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion. Nature 403 (2000) 430-434
56. Demyttenaere K., De Fruyt J., and Stahl S.M. The many faces of fatigue in major depressive disorder. International Journal of Neuropsychopharmacology 8 (2005) 93-105
57. Depue R.A., and Iacono W.G. Neurobehavioral aspects of affective disorders. Annual Reviews in Psychology 40 (1989) 457-492
58. Deroche V., Piazza P.V., Maccari S., Le Moal M., and Simon H. Repeated corticosterone administration sensitizes the locomotor response to amphetamine. Brain Research 584 (1992) 309-313
59. Di Chiara G., Loddo P., and Tanda G. Reciprocal changes in prefrontal and limbic dopamine responsiveness to aversive and rewarding stimuli after chronic mild stress: implications for the psychobiology of depression. Biological Psychiatry 46 (1999) 1624-1633
60. Dinan T.G., Lavelle E., Cooney J., Burnett F., Scott L., Dash A., Thakore J., and Berti C. Dexamethasone augmentation in treatment-resistant depression. Acta Psychiatrica Scandinavica 95 (1997) 58-61
61. Do T., Kerr B., and Kuzhikandathil E.V. Brain-derived neurotrophic factor regulates the expression of D-1 dopamine receptors. Journal of Neurochemistry 100 (2007) 416-428
62. Drevets W.C. Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders. Current Opinion in Neurobiology 11 (2001) 240-249
63. Drouin C., Darracq L., Trovero F., Blanc G., Glowinski J., Cotecchia S., and Tassin J. a1b-Adrenergic receptors control locomotor and rewarding effects of psychostimulants and opiates. Journal of Neuroscience 22 (2002) 2873-2884
64. Duman R.S., and Monteggia L.M. A neurotrophic model for stress-related mood disorders. Biological Psychiatry 59 (2006) 1116-1127
65. Duncan G.E., Breese G.R., Criswell H., Stumpf W.E., Mueller R.A., and Covey J.B. Effects of antidepressant drugs injected into the amygdala on behavioral responses of rats in the forced swim test. Journal of Pharmacology and Experimental Therapeutics 238 (1986) 758-762
66. Esposito E. Serotonin-dopamine interaction as a focus of novel antidepressant drugs. Current Drug Targets 7 (2006) 177-185
67. Farina B., Della Marca G., Grochocinski V.J., Mazza M., Buysse D.J., Di Giannantonio M., Mennuni G.F., De Risio S., Kupfer D.J., and Frank E. Microstructure of sleep in depressed patients according to the cyclic alternating pattern. Journal of Affective Disorders 77 (2003) 227-235
68. Floresco S.B., Magyar O., Ghods-Sharifi S., Vexelman C., and Tse M.T. Multiple dopamine receptor subtypes in the medial prefrontal cortex of the rat regulate set-shifting. Neuropsychopharmacology 31 (2006) 297-309
69. 2-adrenoceptors. Physiology and Behavior 73 (2001) 293-300
70. Forray M.I., and Gysling K. Role of noradrenergic projections to the bed nucleus of the stria terminalis in the regulation of the hypothalamic-pituitary-adrenal axis. Brain Research Reviews 47 (2004) 145-160
71. Frazer A., Lucki I., and Sills M. Alterations in monoamine-containing neuronal function due to administration of antidepressants repeatedly to rats. Acta Pharmacologica et Toxicologica 56 Suppl. 1 (1985) 21-34
72. Frodl T., Meisenzahl E., Zetzsche T., Bottlender R., Born C., Groll C., Jäger M., Leinsinger G., Hahn K., and Möller H.J. Enlargement of the amygdala in patients with a first episode of major depression. Biological Psychiatry 51 (2002) 708-714
73. Fuchs E., Czeh B., and Flugge G. Examining novel concepts of the pathophysiology of depression in the chronic psychosocial stress paradigm in tree shrews. Behavioural Pharmacology 15 (2004) 315-325
74. Fuxe K., Agnati L.F., Jacobsen K., Hillion J., Canals M., Torvinen M., Tinner-Staines B., Staines W., Rosin D., Terasmaa A., Popoli P., Leo G., Vergoni V., Lluis C., Ciruela F., Franco R., and Ferre S. Receptor heteromerization in adenosine A2A receptor signaling: relevance for striatal function and Parkinson's disease. Neurology 61 (2003) S19-S23
75. Gannon M.N., and McEwen B.S. Calmodulin involvement in stress- and corticosterone-induced down-regulation of cyclic AMP-generating systems in brain. Journal of Neurochemistry 55 (1990) 276-284
76. Garcia C., Chen M.J., Garza A.A., Cotman C.W., and Russo-Neustadt A. The influence of specific noradrenergic and serotonergic lesions on the expression of hippocampal brain-derived neurotrophic factor transcripts following voluntary physical activity. Neuroscience 119 (2003) 721-732
77. Garcia-Sevilla J.A., Escriba P.V., Ozaita A., La Harpe R., Walzer C., Eytan A., and Guimon J. Up-regulation of immunolabeled alpha2A-adrenoceptors, Gi coupling proteins, and regulatory receptor kinases in the prefrontal cortex of depressed suicides. Journal of Neurochemistry 72 (1999) 282-291
78. Gershon A.A., Vishne T., and Grunhaus L. Dopamine D2-like receptors and the antidepressant response. Biological Psychiatry 61 (2007) 145-153
79. Gold P., and Chrousos G. Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states. Molecular Psychiatry 7 (2002) 254-262
80. Gold P.W., Goodwin F.K., and Chrousos G.P. Clinical and biochemical manifestations of depression. New England Journal of Medicine 319 (1988) 413-420
81. Goldapple K., Segal Z., Garson C., Lau M., Bieling P., Kennedy S., and Mayberg H. Modulation of cortical-limbic pathways in major depression-treatment-specific effects of cognitive behavior therapy. Archives of General Psychiatry 61 (2004) 34-41
82. Goldman-Rakic P.S., Lidow M.S., and Gallager D.W. Overlap of dopaminergic, adrenergic, and serotoninergic receptors and complementarity of their subtypes in primate prefrontal cortex. Journal of Neuroscience 10 (1990) 2125-2138
83. Gonzalez C., Regunathan S., Reis D.J., and Estrada C. Agmatine, an endogenous modulator of noradrenergic neurotransmission in the rat tail artery. British Journal of Pharmacology 119 (1996) 677-684
84. Grant M.M., and Weiss J. Effects of chronic antidepressant drug administration and electroconvulsive shock on locus coeruleus electrophysiologic activity. Biological Psychiatry 49 (2001) 117-129
85. Green T.A., Alibhai I.N., Hommel J.D., DiLeone R.J., Kumar A., Theobald D.E., Neve R.L., and Nestler E.J. Induction of inducible cAMP early repressor expression in nucleus accumbens by stress or amphetamine increases behavioral responses to emotional stimuli. Journal of Neuroscience 26 (2006) 8235-8242
86. Greenwood B.N., Foley T.E., Burhans D., Maier S.F., and Fleshner M. The consequences of uncontrollable stress are sensitive to duration of prior wheel running. Brain Research 1033 (2005) 164-178
87. Gregus A., Wintink A.J., Davis A.C., and Kalynchuk L.E. Effect of repeated corticosterone injections and restraint stress on anxiety and depression-like behavior in male rats. Behavioural Brain Research 156 (2005) 105-114
88. Grillner S., Hellgren J., Menard A., Saitoh K., and Wikstrom M.A. Mechanisms for selection of basic motor programs-roles for the striatum and pallidum. Trends in Neuroscience 28 (2005) 364-370
89. 1B receptor knockout mice in stress and anxiety paradigms. Behavioural Pharmacology 14 (2003) 369-383
90. 1B receptor activity in rat brain: in vivo microdialysis studies. European Journal of Pharmacology 411 (2001) 115-122
91. Habib K.E., Gold P.W., and Chrousos G.P. Neuroendocrinology of stress. Endocrinology and Metabolism Clinics of North America 30 (2001) 695-728
92. Hammack S.E., Richey K.J., Schmid M.J., LoPresti M.L., Watkins L.R., and Maier S.F. The role of corticotropin-releasing hormone in the dorsal raphe nucleus in mediating the behavioral consequences of uncontrollable stress. Journal of Neuroscience 22 (2002) 1020-1026
93. 1-Adrenoceptor subtypes: a synopsis of their pharmacology and molecular biology. Drug Development Research 39 (1996) 54-107
94. Harris A.H.S., Cronkite R., and Moos R. Physical activity, exercise coping, and depression in a 10-year cohort study of depressed patients. Journal of Affective Disorders 93 (2006) 79-85
95. Hayley S., Poulter M.O., Merali Z., and Anisman H. The pathogenesis of clinical depression: stressor- and cytokine-induced alterations of neuroplasticity. Neuroscience 135 (2005) 659-678
96. Heinrichs S.C., and Koob G.F. Corticotropin-releasing factor in brain: a role in activation, arousal, and affect regulation. Journal of Pharmacology and Experimental Therapeutics 311 (2004) 427-440
97. Herman J.P., and Cullinan W.E. Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis. Trends Neuroscience 20 (1997) 78-84
98. Herman J.P., and Mueller N.K. Role of the ventral subiculum in stress integration. Behavioural Brain Research 174 (2006) 215-224
99. Herman J.P., Stinus L., and LeMoal M. Repeated stress increases locomotor response to amphetamine. Psychopharmacology 84 (1984) 431-435
100. Het S., and Wolf O.T. Mood changes in response to psychosocial stress in healthy young women: effects of pretreatment with cortisol. Behavioral Neuroscience 121 (2007) 11-20
101. Hoffman G.E., and Lyo D. Anatomical markers of activity in neuroendocrine systems: are we all 'fos-ed out'?. Journal of Neuroendocrinology 14 (2002) 259-268
102. Hollis J.H., Evans A.K., Bruce K.P., Lightman S.L., and Lowry C.A. Lipopolysaccharide has indomethacin-sensitive actions on Fos expression in topographically organized subpopulations of serotonergic neurons. Brain Behavior and Immunity 20 (2006) 569-577
103. Holsboer F. Stress, hypercortisolism and corticosteroid receptors in depression: implicatons for therapy. Journal of Affective Disorders 62 (2001) 77-91
104. Huang G.J., and Herbert J. Stimulation of neurogenesis in the hippocampus of the adult rat by fluoxetine requires rhythmic change in corticosterone. Biological Psychiatry 59 (2006) 619-624
105. Huzarska M., Zielinski M., and Herman Z.S. Repeated treatment with antidepressants enhances dopamine D1 receptor gene expression in the rat brain. European Journal of Pharmacology 532 (2006) 208-213
106. 2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites. Proceedings of the National Academy of Sciences of the United States of America 95 (1998) 735-740
107. Jakab R.L., and Goldman-Rakic P.S. Segregation of serotonin 5-HT2A and 5-HT3 receptors in inhibitory circuits of the primate cerebral cortex. Journal of Comparative Neurology 417 (2000) 337-348
108. Janowsky D.S., el Yousef M.K., and Davis J.M. Acetylcholine and depression. Psychosomatic Medicine 36 (1974) 248-257
109. Joels M., and DeKloet E.R. Effects of glucocorticoids and norepinephrine on the excitability in the hippocampus. Science 245 (1989) 1502-1505
110. Johnson R.W., Propes M.J., and Shavit Y. Corticosterone modulates behavioral and metabolic effects of lipopolysaccharide. American Journal of Physiology 270 (1996) R192-R198
111. Jovanovic J.N., Czernik A.J., Fienberg A.A., Greengard P., and Sihra T.S. Synapsins as mediators of BDNF-enhanced neurotransmitter release. Nature Neuroscience 3 (2000) 323-329
112. Juric D.M., Miklic S., and Carman-Krzan M. Monoaminergic neuronal activity up-regulates BDNF synthesis in cultured neonatal rat astrocytes. Brain Research 1108 (2006) 54-62
113. Jutkiewicz E.M., Wood S.K., Houshyar H., Hsin L.W., Rice K.C., and Woods J.H. The effects of CRF antagonists, antalarmin, CP154,526, LWH234, and R121919, in the forced swim test and on swim-induced increases in adrenocorticotropin in rats. Psychopharmacology 180 (2005) 215-223
114. Kalivas P.W., and Duffy P. Selective activation of dopamine transmission in the shell of the nucleus accumbens by stress. Brain Research 675 (1995) 325-328
115. Kalivas P.W., Duffy P., and Latimer L.G. Neurochemical and behavioral effects of corticotropin-releasing factor in the ventral tegmental area of the rat. Journal of Pharmacology and Experimental Therapeutics 242 (1987) 757-763
116. Kareken D.A., Sabri M., Radnovich A.J., Claus E., Foresman B., Hector D., and Hutchins G.D. Olfactory system activation from sniffing: effects in piriform and orbitofrontal cortex. NeuroImage 22 (2004) 456-465
117. Kauffman A.S., Buenzle J., Fraley G.S., and Rissman E.F. Effects of galanin-like peptide (GALP) on locomotion, reproduction, and body weight in female and male mice. Hormones and Behavior 48 (2005) 141-151
118. Kenney M.J., Weiss M.L., Patel K.P., Wang Y., and Fels R.J. Paraventricular nucleus bicuculline alters frequency components of sympathetic nerve discharge bursts. American Journal of Physiology 281 (2001) H1233-H1241
119. Ketter T.A., Kimbrell T.A., George M.S., Dunn R.T., Speer A.M., Benson B.E., Willis M.W., Danielson A., Frye M.A., Herscovitch P., and Post R.M. Effects of mood and subtype on cerebral glucose metabolism in treatment-resistant bipolar disorder. Biological Psychiatry 49 (2001) 97-109
120. 1-adrenergic receptors in the regulation of corticotropin-releasing hormone mRNA in the paraventricular nucleus of the hypothalamus during stress. Cell and Molecular Neurobiology 20 (2000) 683-694
121. Koh S., Magid R., Chung H., Stine C.D., and Wilson D.N. Depressive behavior and selective downregulation of serotonin receptor expression after early-life seizures: reversal by environmental enrichment. Epilepsy Behavior 10 (2007) 26-31
122. Kollack-Walker S., Watson S.J., and Akil H. Social stress in hamsters: defeat activates specific neurocircuits within the brain. Journal of Neuroscience 17 (1997) 8842-8855
123. Kostowski W. Two noradrenergic systems in the brain and their interactions with other monoaminergic neurons. Polish Journal of Pharmacology and Pharmacy 31 (1979) 425-436
124. Kroes R.A., Panksepp J., Burgdorf J., Otto N.J., and Moskal J.R. Modeling depression: social dominance-submission gene expression patterns in rat neocortex. Neuroscience 137 (2006) 37-49
125. Kroes R.A., Burgdorf J., Panksepp J., and Moskal J.R. Social defeat, a paradigm of depression in rats that elicits 22-kHz vocalizations, preferentially activates the cholinergic signaling pathway in the periaqueductal gray. Behavioural Brain Research 182 (2007) 290-300
126. Kuhn H.G., Cooper-Kuhn C., Eriksson P., and Nilsson M. Signals regulating neurogenesis in the adult olfactory bulb. Chemical Senses 30 (2005) I109-I110
127. 1 receptor agonists in the mouse forced swim test. British Journal of Pharmacology 123 (1998) 1331-1336
128. Lanser M.G., Ellenbroek B.A., Zitman F.G., Heeren D.J., and Cools A.R. The role of medial prefrontal cortical dopamine in spontaneous flexibility in the rat. Behavioural Pharmacology 12 (2001) 163-171
129. Lehmann, M., Stone, E., 2006. Environmental enrichment prevents the development of depression in mice exposed to chronic unavoidable social stress. Abstract Viewer/Itinerary Planner Program No. 808.14.
130. Leonard B.E., and Song C. Stress, depression, and the role of cytokines. Advances in Experimental Medicine and Biology 461 (1999) 251-265
131. Lesselyong, A., Chen, M., Russo-Neustadt, A., 2005. Norepinephrine leads to enhanced BDNF immunoreactivity in hippocampal neuronal cultures in an no-dependent manner. Abstract Viewer/Itinerary Planner. Washington, DC, Society for Neuroscience Program No. 148.22.
132. Lestage J., Verrier D., Palin K., and Dantzer R. The enzyme indoleamine 2,3-dioxygenase is induced in the mouse brain in response to peripheral administration of lipopolysaccharide and superantigen. Brain Behavior and Immunity 16 (2002) 596-601
133. 1-adrenoceptors of the locus coeruleus in self-stimulation of the medial forebrain bundle. Neuropsychopharmacology 32 (2007) 835-841
134. Lipinski J.F., Cohen B.M., Zubenko G.S., and Waternaux C. Adrenoceptors and the pharmacology of affective illness: a unifying theory. Life Science 40 (1987) 1947-1963
135. MacDonald E., and Scheinin M. Distribution and pharmacology of alpha2-adrenoceptors in the central nervous system. Journal of Physiology and Pharmacology 46 (1995) 241-258
136. Macedo C.E., Martinez R.C.R., AlbrechetSouza L., Molina V.A., and Brandao M.L. 5-HT2- and D-1-mechanisms of the basolateral nucleus of the amygdala enhance conditioned fear and impair unconditioned fear. Behavioural Brain Research 177 (2007) 100-108
137. Maier S.F., and Watkins L.R. Stressor controllability and learned helplessness: the roles of the dorsal raphe nucleus, serotonin, and corticotropin-releasing factor. Neuroscience and Biobehavioral Reviews 29 (2005) 829-841
138. Maier S.F., Grahn R.E., and Watkins L.R. 8-OH-DPAT microinjected in the region of the dorsal raphe nucleus blocks and reverses the enhancement of fear conditioning and interference with escape produced by exposure to inescapable shock. Behavioral Neuroscience 109 (1995) 404-412
139. 1-adrenergic, dopamine and serotonin systems. Journal of Neural Transmission 106 (1999) 197-211
140. Makino S., Gold P.W., and Schulkin J. Corticosterone effects on corticotropin-releasing hormone mRNA in the central nucleus of the amygdala and the parvocellular region of the paraventricular nucleus of the hypothalamus. Brain Research 640 (1994) 105-112
141. Marvel F.A., Chen C.C., Badr N., Gaykema R.P., and Goehler L.E. Reversible inactivation of the dorsal vagal complex blocks lipopolysaccharide-induced social withdrawal and c-fos expression in central autonomic nuclei. Brain Behavior and Immunity 18 (2004) 123-134
142. Mayberg H., Liotti M., Brannan S., McGinnis S., Mahurin K., Jerabek P., Silva J.A., Tekell J.L., Martin C.C., Lancaster J.L., and Fox P.T. Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. American Journal of Psychiatry 156 (1999) 675-682
143. Mayberg H.S., Brannan S.K., Tekell J.L., Silva J.A., Mahurin R.K., McGinnis S., and Jerabek P.A. Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biological Psychiatry 48 (2000) 830-843
144. Mayberg H.S., Lozano A.M., Voon V., McNeely H.E., Seminowicz D., Hamani C., Schwalb J.M., and Kennedy S.H. Deep brain stimulation for treatment-resistant depression. Neuron 45 (2005) 651-660
145. McEwen B.S. The neurobiology of stress: from serendipity to clinical relevance. Brain Research 886 (2000) 172-189
146. McEwen B.S. Mood disorders and allostatic load. Biological Psychiatry 54 (2003) 200-207
147. McEwen B.S. Glucocorticoids, depression, and mood disorders: structural remodeling in the brain. Metabolism 54 (2005) 20-23
148. Merrick W. The experience of psychopathology: investigating mental disorders in their natural settings. In: Vries M.D. (Ed). Dysphoric Moods in Depressed and Non-depressed Adolescents (1992), Cambridge University Press, Cambridge 148-156
149. Meyer J.H., Ginovart N., Boovariwala A., Sagrati S., Hussey D., Garcia A., Young T., Praschak-Rieder N., Wilson A.A., and Houle S. Elevated monoamine oxidase a levels in the brain: an explanation for the monoamine imbalance of major depression. Archives of General Psychiatry 63 (2006) 1209-1216
150. Miczek K.A., Nikulina E., Kream R.M., Carter G., and Espejo E.F. Behavioral sensitization to cocaine after a brief social defeat stress: c-fos expression in the PAG. Psychopharmacology 141 (1999) 225-234
151. 2A receptors suppresses the induction of locomotor activity by 5-HT reuptake inhibitors, citalopram and fluvoxamine, in NMRI mice exposed to a novel environment: a comparison to other 5-HT receptor subtypes. Psychopharmacology 168 (2003) 397-409
152. Minor T.R., Chang W.-C., and Winslow J.L. Stress and adenosine: I. Effect of methylxanthine and amphetamine stimulants on learned helplessness in rats. Behavioral Neuroscience 108 (1994) 254-264
153. Monnikes H., Heymann-Monnikes I., and Tache Y. CRF in the paraventricular nucleus of the hypothalamus induces dose-related behavioral profile in rats. Brain Research 574 (1992) 70-76
154. Mucignat-Caretta C., Bondi M., and Caretta A. Time course of alterations after olfactory bulbectomy in mice. Physiology and Behavior 89 (2006) 637-643
155. Mueller M.B., and Holsboer F. Mice with mutations in the HPA-system as models for symptoms of depression. Biological Psychiatry 59 (2006) 1104-1115
156. Nemeroff C. Recent advances in the neurobiology of depression. Psychopharmacology Bulletin 36 Suppl. 2 (2002) 6-23
157. Nestler E.J., and Carlezon Jr. W.A. The mesolimbic dopamine reward circuit in depression. Biological Psychiatry 59 (2006) 1151-1159
158. Neumeister A., Drevets W.C., Belfer I., Luckenbaugh D.A., Henry S., Bonne O., Herscovitchs P., Goldman D., and Charney D.S. Effects of alpha2C-adrenoreceptor gene polymorphism on neural responses to facial expressions in depression. Neuropsychopharmacology 31 (2006) 1750-1756
159. Nieto M.M., Guen S.L.E., Kieffer B.L., Roques B.P., and Noble F. Physiological control of emotion-related behaviors by endogenous enkephalins involves essentially the delta opioid receptors. Neuroscience 135 (2005) 305-313
160. Nikulina E.M., Covington III H.E., Ganschow L., Hammer Jr. R.P., and Miczek K.A. Long-term behavioral and neuronal cross-sensitization to amphetamine induced by repeated brief social defeat stress: fos in the ventral tegmental area and amygdala. Neuroscience 123 (2004) 857-865
161. Nutt D.J. Noradrenaline in depression: half a century of progress. Journal of Psychopharmacology 11 (1997) S3
162. Nyberg L., Eriksson J., Larsson A., and Marklund P. Learning by doing versus learning by thinking: an fMRI study of motor and mental training. Neuropsychologia 44 (2006) 711-717
163. O'Neill M.F., Hicks C.A., Shaw G., Parameswaran T., Cardwell G.P., and O'Neill M.J. Effects of 5-hydroxytryptamine, receptor antagonism on the behavioral activation and immediate early gene expression induced by dizocilpine. Journal of Pharmacology and Experimental Therapeutics 287 (1998) 839-846
164. Oathes D.J., and Ray W.J. Depressed mood, index finger force and motor cortex stimulation: a transcranial magnetic stimulation (JMS) study. Biological Psychology 72 (2006) 271-277
165. Ossowska G., Nowak G., Kata R., Klenk-Majewska B., Danilczuk Z., and Zebrowska-Lupina F. Brain monoamine receptors in a chronic unpredictable stress model in rats. Journal of Neural Transmission 108 (2001) 311-319
166. Ostrander M.M., Badiani A., Day H.E., Norton C.S., Watson S.J., Akil H., and Robinson T.E. Environmental context and drug history modulate amphetamine-induced c-fos mRNA expression in the basal ganglia, central extended amygdala, and associated limbic forebrain. Neuroscience 120 (2003) 551-571
167. Overstreet D.H., Keeney A., and Hogg S. Antidepressant effects of citalopram and CRF receptor antagonist CP-154,526 in a rat model of depression. European Journal of Pharmacology 492 (2004) 195-201
168. Paddon-Jones D., Sheffield-Moore M., Cree M.G., Hewlings S.J., Aarsland A., Wolfe R.R., and Ferrando A.A. Atrophy and impaired muscle protein synthesis during prolonged inactivity and stress. Journal of Clinical Endocrinology and Metabolism 91 (2006) 4836-4841
169. 1A receptor expression in pyramidal neurons of cortical and limbic brain regions. Cell and Tissue Research 321 (2005) 159-172
170. Papale L.A., Andersen M.L., Antunes I.B., Alvarenga T.A.F., and Tufik S. Sleep pattern in rats under different stress modalities. Brain Research 1060 (2005) 47-54
171. 1B-adrenergic receptor is expressed in neurons and NG2 oligodendrocytes. Journal of Comparative Neurology 478 (2004) 1-10
172. Papay R., Gaivin R., Jha A., McCune D.F., McGrath J.C., Rodrigo M.C., Simpson P.C., Doze V.A., and Perez D.M. Localization of the mouse alpha1A-adrenergic receptor (AR) in the brain: alpha1AAR is expressed in neurons, GABAergic interneurons, and NG2 oligodendrocyte progenitors. Journal of Comparative Neurology 497 (2006) 209-222
173. Pascoli V., Valjent E., Corbillé A.G., Corvol J.C., Tassin J.P., Girault J.A., and Hervé D. cAMP and extracellular signal-regulated kinase signaling in response to D-amphetamine and methylphenidate in the prefrontal cortex in vivo: role of b1-adrenoceptors. Molecular Pharmacology 68 (2005) 421-429
174. Pasqualetti M., Ori M., Castagna M., Marazziti D., Cassano G.B., and Nardi I. Distribution and cellular localization of the serotonin type 2C receptor messenger RNA in human brain. Neuroscience 92 (1999) 601-611
175. Perrin D., Mamet J., Géloën A., Morel G., Dalmaz Y., and Pequignot J.M. Sympathetic and brain monoaminergic regulation of energy balance in obesity-resistant rats (Lou/C). Autonomic Neuroscience 109 (2003) 1-9
176. Pezeshki G., Pohl T., and Schobitz B. Corticosterone controls interleukin-1beta expression and sickness behavior in the rat. Journal of Neuroendocrinology 8 (1996) 129-135
177. Piazza P.V., Deminiere J.M., Le Moal M., and Simon H. Stress- and pharmacologically-induced hehavioral sensitization increases vulnerability to acquisition of amphetamine self-administration. Brain Research 514 (1990) 22-26
178. Pizarro J.M., Lumley L.A., Medina W., Robison C.L., Chang W.L.E., Alagappan A., Bah M.J., Dawood M.Y., Shah J.D., Mark B., Kendall N., Smith M.A., Saviolakis G.A., and Meyerhoff J.L. Acute social defeat reduces neurotrophin expression in brain cortical and subcortical areas in mice. Brain Research 1025 (2004) 10-20
179. Porsolt R.D., Anton G., Blavet N., and Jalfre M. Behavioral despair in rats: a new model sensitive to antidepressant treatments. European Journal of Pharmacology 47 (1978) 379-381
180. Possidente B., Lumia A.R., McGinnis M.Y., Pratt C., and Page C. Chronobiological dimensions of an olfactory bulbectomized rodent animal model for agitated depression. Biological Rhythm Research 31 (2000) 416-434
181. Quartermain, D., Lin, Y., Stone, E., 2007. Central fos expression during the performance of a well-learned approach response. Submitted for publication.
182. Reber S.O., Birkeneder L., Veenema A.H., Obermeier F., Falk W., Straub R.H., and Neumann I.D. Adrenal insufficiency and colonic inflammation after a novel chronic psycho-social stress paradigm in mice: implications and mechanisms. Endocrinology 148 (2007) 670-682
183. Reyes B.A.S., Valentino R.J., Xu G.P., and Van Bockstaele E.J. Hypothalamic projections to locus coeruleus neurons in rat brain. European Journal of Neuroscience 22 (2005) 93-106
184. Reynolds J.L., Ignatowski T.A., Sud R., and Spengler R.N. An antidepressant mechanism of desipramine is to decrease tumor necrosis factor-alpha production culminating in increases in noradrenergic neurotransmission. Neuroscience 133 (2005) 519-531
185. Rhodes J.S., Garland Jr. T., and Gammie S.C. Patterns of brain activity associated with variation in voluntary wheel-running behavior. Behavioral Neuroscience 117 (2003) 1243-1256
186. Rios M., Lambe E.K., Liu R.J., Teillon S., Liu J.H., Akbarian S., Roffler-Tarlov S., Jaenisch R., and Aghajanian G.K. Severe deficits in 5-HT2A-mediated neurotransmission in BDNF conditional mutant mice. Journal of Neurobiology 66 (2006) 408-420
187. Rizk, P., Marien, M., Colpaert, F., Raisman-Vozari, R., Debeir, T., 2004. Influence of noradrenergic activation by the alpha-2 adrenoceptor antagonist dexefaroxan on neurogenesis in the hippocampus of the adult rat brain. Abstract View/Itin. Plan., Soc. Neurosci., Washington, DC, Online, Program no. 607.16-000.
188. Sajdyk T., and Gehlert D. Astressin, a corticotropin releasing factor antagonist, reverses the anxiogenic effects of urocortin when administered into the basolateral amygdala. Brain Research 877 (2000) 226-234
189. Sandi C., Venero C., and Guaza C. Novelty-related rapid locomotor effects of corticosterone in rats. European Journal of Neuroscience 8 (1996) 794-800
190. Santarelli L., Saxe M., Gross C., Surget A., Battaglia F., Dulawa S., Weisstaub N., Lee J., Duman R., Arancio O., Belzung C., and Hen R. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301 (2003) 805-809
191. Schaaf M.J.M., Hoetelmans R.W.M., de Kloet E.R., and Vreugdenhil E. Corticosterone regulates expression of BDNF and trkB but not NT- 3 and trkC mRNA in the rat hippocampus. Journal of Neuroscience Research 48 (1997) 334-341
192. Schelling G., Briegel J., Roozendaal B., Stoll C., Rothenhäusler H.B., and Kapfhammer H.P. The effect of stress doses of hydrocortisone during septic shock on posttraumatic stress disorder in survivors. Biological Psychiatry 50 (2001) 978-985
193. Schildkraut J.J. The catecholamine hypothesis of affective disorders: a review of the supporting evidence. American Journal of Psychiatry 122 (1965) 509-522
194. Schule C. Neuroendocrinological mechanisms of actions of antidepressant drugs. Journal of Neuroendocrinology 19 (2007) 213-226
195. Schweimer J., and Hauber W. Dopamine D1 receptors in the anterior cingulate cortex regulate effort-based decision making. Learning & Memory 13 (2006) 777-782
196. Schweimer J., Saft S., and Hauber W. Involvement of catecholamine neurotransmission in the rat anterior cingulate in effort-related decision making. Behavioral Neuroscience 119 (2005) 1687-1692
197. 1 receptors in orexin A-induced wakefulness in rats. Brain Research 1023 (2004) 121-125
198. Shumake J., Edwards E., and Gonzalez-Lima F. Hypermetabolism of paraventricular hypothalamus in the congenitally helpless rat. Neuroscience Letters 311 (2001) 45-48
199. Siegle G.J., Thompson W., Carter C.S., Steinhauer S.R., and Thase M.E. Increased amygdala and decreased dorsolateral prefrontal BOLD responses in unipolar depression: related and independent features. Biological Psychiatry 61 (2007) 198-209
200. Siever L.J., and Davis K.L. Dysregulation of the noradrenergic system in depression. Psychopharmacology Bulletin 20 (1984) 500-504
201. Simson P.G., Weiss J., Hoffman L.J., and Ambrose M.J. Reversal of behavioral depression by infusion of an alpha-2 adrenergic agonist into the locus coeruleus. Neuropharmacology 25 (1986) 385-389
202. Song C., and Leonard B.E. The olfactory bulbectomised rat as a model of depression. Neuroscience and Biobehavioral Reviews 29 (2005) 627-647
203. Sonino N., Fava G.A., Raffi A.R., Boscaro M., and Fallo F. Clinical correlates of major depression in Cushing's disease. Psychopathology 31 (1998) 302-306
204. Spencer S.J., and Day T.A. Role of catecholaminergic inputs to the medial prefrontal cortex in local and subcortical expression of fos after psychological stress. Journal of Neuroscience Research 78 (2004) 279-288
205. 1A receptor downregulation by antidepressants in rat brain. Neurochemistry International 38 (2001) 573-579
206. Staiger J.F., Bisler S., Schleicher A., Gass P., Stehle J.H., and Zilles K. Exploration of a novel environment leads to the expression of inducible transcription factors in barrel-related columns. Neuroscience 99 (2000) 7-16
207. Steciuk M., Kram M., Kramer G.L., and Petty F. Decrease in stress-induced c-Fos-like immunoreactivity in the lateral septal nucleus of learned helpless rats. Brain Research 822 (1999) 256-259
208. Stone, E., Lin, Y., 2007. An acute anti-immobility effect of exogenous corticosterone in mice. European Journal of Pharmacology, in press.
209. Stone E.A., McEwen B.S., Herrera A.S., and Carr K.D. Regulation of a and b components of noradrenergic cyclic AMP response in cortical slices. European Journal of Pharmacology 141 (1987) 347-356
210. Stone E., Lin Y., Itteera A., and Quartermain D. Pharmacological evidence for the role of brain alpha 1B-adrenergic receptors in the motor activity and spontaneous movement of mice. Neuropharmacology 40 (2001) 254-261
211. Stone E., Lin Y., Suckow R., and Quartermain D. Stress-induced subsensitivity to modafinil and its prevention by corticosteroids. Pharmacology Biochemistry and Behavior 73 (2002) 971-978
212. Stone E., Lin Y., Ahsan R., and Quartermain D. Gross mapping of a1-adrenoceptors that regulate behavioral activation in the mouse brain. Behavioural Brain Research 152 (2004) 167-175
213. Stone E., Lehmann M., Lin Y., and Quartermain D. Depressive behavior in mice due to immune stimulation is accompanied by reduced neural activity in brain regions involved in positively motivated behavior. Biological Psychiatry 60 (2006) 803-811
214. Stone E., Lin Y., Ahsan M., Lehmann M., Yeretsian J., and Quartermain D. Role of CNS alpha-1 adrenoceptor activity in central fos responses to novelty. Synapse 59 (2006) 299-307
215. Stone E., Lehmann M., Lin Y., and Quartermain D. Reduced evoked fos expression in activity-related brain regions in animal models of depression. Progress in Neuropsychopharmacology and Biological Psychiatry 31 (2007) 1196-1207
216. Stone, E., Lin, Y., Quartermain, D., 2007b. Possible dopaminergic stimulation of alpha-1 adrenoceptors in locus coeruleus involved in behavioral activation. Abstract Viewer/Itinerary Planner. Society for Neuroscience, Washington, DC.
217. 1-adrenergic system in behavioral activity and depression. Biochemical Pharmacology 73 (2007) 1063-1075
218. Stout S.C., Mortas P., Owens M.J., Nemeroff C.B., and Moreau J.L. Increased corticotropin-releasing factor concentrations in the bed nucleus of the stria terminalis of anhedonic rats. European Journal of Pharmacology 401 (2000) 39-46
219. Strekalova T., Spanagel R., Dolgov O., and Bartsch D. Stress-induced hyperlocomotion as a confounding factor in anxiety and depression models in mice. Behavioural Pharmacology 16 (2005) 171-180
220. Sulser F. Antidepressant drug research: its impact on neurobiology and psychobiology. In: Costa E., and Racagni G. (Eds). Typical and Atypical Antidepressants: Molecular Mechanisms (1982), Raven Press, New York 1-20
221. Surmeier D.J., Song W.J., and Yan Z. Coordinated expression of dopamine receptors in neostriatal medium spiny neurons. Journal of Neuroscience 16 (1996) 6579-6591
222. Svenningsson P., Lindskog M., Rognoni F., Fredholm B.B., Greengard P., and Fisone G. Activation of adenosine A2A and dopamine D1 receptors stimulates cyclic AMP-dependent phosphorylation of DARPP-32 in distinct populations of striatal projection neurons. Neuroscience 84 (1998) 223-228
223. Swanson L. Cerebral hemisphere regulation of motivated behavior. Brain Research 886 (2000) 113-164
224. Tabuchi E., Furusawa A.A., Hori E., Umeno K., Ono T., and Nishijo H. Neural correlates to action and rewards in the rat posterior cingulate cortex. Neuroreport 16 (2005) 949-953
225. Tenk C.M., Kavaliers M., and Ossenkopp K.P. The effects of acute corticosterone on lithium chloride-induced conditioned place aversion and locomotor activity in rats. Life Science 79 (2006) 1069-1080
226. Tremblay L.K., Naranjo C.A., Graham S.J., Herrmann N., Mayberg H.S., Hevenor S., and Busto U.E. Functional neuroanatomical substrates of altered reward processing in major depressive disorder revealed by a dopaminergic probe. Archives of General Psychiatry 62 (2005) 1228-1236
227. Tsankova N.M., Berton O., Renthal W., Kumar A., Neve R.L., and Nestler E.J. Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nature Neuroscience 9 (2006) 519-525
228. Valdés J.L., Farías P., Ocampo-Garcés A., Cortés N., Serón-Ferré M., and Torrealba F. Arousal and differential Fos expression in histaminergic neurons of the ascending arousal system during a feeding-related motivated behaviour. European Journal of Neuroscience 21 (2005) 1931-1942
229. Van Bockstaele E.J., Peoples J., and Telegan P. Efferent projections of the nucleus of the solitary tract to peri-locus coeruleus dendrites in rat brain: Evidence for a monosynaptic pathway. Journal of Comparative Neurology 412 (1999) 410-428
230. Van Bockstaele E.J., Bajic D., Proudfit H., and Valentino R.J. Topographic architecture of stress-related pathways targeting the noradrenergic locus coeruleus. Physiology and Behavior 73 (2001) 273-283
231. Vijayraghavan S., Wang M., Birnbaum S.G., Williams G.V., and Arnsten A.F. Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory. Nature Neuroscience 10 (2007) 376-384
232. Weiss J., Bonsall R.W., Demetrikopoulos M.K., Emery M.S., and West C.H.K. Galanin: a significant role in depression?. Annual New York Academy of Sciences 863 (1998) 364-382
233. Weiss J.M., Boss-Williams K.A., Moore J.P., Demetrikopoulos M.K., Ritchie J.C., and West C.H.K. Testing the hypothesis that locus coeruleus hyperactivity produces depression-related changes via galanin. Neuropeptides 39 (2005) 281-287
234. Willins D.L., Deutch A.Y., and Roth B.L. Serotonin 5-HT2A receptors are expressed on pyramidal cells and interneurons in the rat cortex. Synapse 27 (1997) 79-82
235. Willner P. Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology 134 (1997) 319-329
236. Wisor J.P., and Eriksson K.S. Dopaminergic-adrenergic interactions in the wake promoting mechanism of modafinil. Neuroscience 132 (2005) 1027-1034
237. Xu T., and Pandey S.C. Cellular localization of serotonin(2A) (5HT(2A)) receptors in the rat brain. Brain Research Bulletin 51 (2000) 499-505
238. Zebrowska-Lupina I. Presynaptic alpha-adrenoceptors and the action of tricyclic antidepressant drugs in behavioural despair in rats. Psychopharmacology 71 (1980) 169-172
239. Zhang H.T., Frith S.A., Wilkins J., and O'Donnell J.M. Comparison of the effects of isoproterenol administered into the hippocampus, frontal cortex, or amygdala on behavior of rats maintained by differential reinforcement of low response rate. Psychopharmacology 159 (2001) 89-97
240. Zifa E., and Fillion G. 5-Hydroxytryptamine receptors. Pharmacological Reviews 44 (1992) 401-458